Your browser doesn't support javascript.
loading
Checkpoint inhibition: protecting against or predisposing for second primary tumors? Reply to the Letter to the Editor 'Checkpoint inhibition: protecting against or predisposing for second primary tumors?' by K. P. M. Suijkerbuijk, A. M. May and M. J. M. van Eijs.
Heudel, P; Chabaud, S; Perol, D; Ray-Coquard, I; Blay, J-Y.
Afiliación
  • Heudel P; Department of Research (CRCL), Centre Léon Bérard, Lyon, France; Department of Medicine, Centre Léon Bérard & Université Claude Bernard, Lyon, France.
  • Chabaud S; Department of Research (CRCL), Centre Léon Bérard, Lyon, France; Department of Clinical Research, Centre Léon Bérard, Lyon, France.
  • Perol D; Department of Research (CRCL), Centre Léon Bérard, Lyon, France; Department of Clinical Research, Centre Léon Bérard, Lyon, France.
  • Ray-Coquard I; Department of Research (CRCL), Centre Léon Bérard, Lyon, France; Department of Medicine, Centre Léon Bérard & Université Claude Bernard, Lyon, France.
  • Blay JY; Department of Research (CRCL), Centre Léon Bérard, Lyon, France; Department of Medicine, Centre Léon Bérard & Université Claude Bernard, Lyon, France; Unicancer, Paris, France; Department of Cancer Initiation and Tumor Cell Identity, Cancer Research Center of Lyon (CRCL), Lyon, France. Electroni
Ann Oncol ; 32(8): 1055-1057, 2021 08.
Article en En | MEDLINE | ID: mdl-33932506

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Primarias Secundarias Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Primarias Secundarias Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Francia